Showing 1 to 2 of 2 results


US GLP-1 Drug Affordability Crisis
High costs and limited insurance coverage of GLP-1 weight-loss drugs like Ozempic and Wegovy are creating an affordability crisis in the US, with millions losing coverage in 2025; potential solutions include allowing compounding pharmacies to produce personalized prescriptions and revoking patent ex...
US GLP-1 Drug Affordability Crisis
High costs and limited insurance coverage of GLP-1 weight-loss drugs like Ozempic and Wegovy are creating an affordability crisis in the US, with millions losing coverage in 2025; potential solutions include allowing compounding pharmacies to produce personalized prescriptions and revoking patent ex...
Progress
52% Bias Score

Proposed Drug Patent Cuts Threaten Medical Innovation
Congress is considering reducing patent protection for pharmaceutical drugs to offset tax cuts, potentially hindering development of life-saving medications due to increased financial risk in research and development, impacting future medical innovation and patient care.

Proposed Drug Patent Cuts Threaten Medical Innovation
Congress is considering reducing patent protection for pharmaceutical drugs to offset tax cuts, potentially hindering development of life-saving medications due to increased financial risk in research and development, impacting future medical innovation and patient care.
Progress
56% Bias Score
Showing 1 to 2 of 2 results